All In Biotech

Drug Trial Radar · NCT04542499

Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults With Motor Fluctuations (TEMPO-3 Trial)

Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 507 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

507

Actual

Start

Sep 23, 2020

Primary completion

Jan 29, 2024

Study completion Feb 15, 2024

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Sep 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the effect of tavapadon on the change from baseline in total daily hours of "on" time without troublesome dyskinesia in L-Dopa-treated participants with Parkinson's Disease (PD) who are experiencing motor fluctuations.

Conditions

  • Parkinson Disease

Interventions

  • TavapadonDrug

    Participants will be randomized to receive tavapadon 5 to 15 mg tablet QD orally for 27 weeks.

  • PlaceboDrug

    Participants will receive placebo matching to tavapadon QD orally for 27 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Total "On" Time Without Troublesome Dyskinesia Based on the 2-day Average of the Self-completed Home Diary for Motor Function Status (Hauser Diary)Time frame: Week 26

Locations

146 sites in 14 countries. Site status is shown where the registry gives one.

  • Pheonix, Arizona

    Phoenix, Arizona

  • Little Rock, Arkansas

    Little Rock, Arkansas

  • Fountain Valley, California

    Fountain Valley, California

  • Fresno, California

    Fresno, California

  • Long beach, California

    Long Beach, California

  • Los Angeles, California

    Los Angeles, California

  • Pasadena, California

    Pasadena, California

  • Reseda, California

    Reseda, California

  • Denver, Colorado

    Denver, Colorado

  • Englewood, Colorado

    Englewood, Colorado

  • Adventura, Florida

    Adventura, Florida

  • Atlantis, Florida

    Atlantis, Florida

  • Boca Raton, Florida

    Boca Raton, Florida

  • Boca Raton, Florida

    Boca Raton, Florida

  • Coral Springs, Florida

    Coral Springs, Florida

  • Hallandale Beach, Florida

    Hallandale, Florida

  • Maitland, Florida

    Maitland, Florida

  • Ocala, Florida

    Ocala, Florida

  • Port Charlotte, Florida

    Port Charlotte, Florida

  • Port Orange, Florida

    Port Orange, Florida

  • Tampa, Florida

    Tampa, Florida

  • Winter Park, Florida

    Winter Park, Florida

  • Augusta, Georgia

    Augusta, Georgia

  • Chicago, Illinois

    Chicago, Illinois

  • Elk Grove Village, Illinois

    Elk Grove Village, Illinois

  • Kansas City, Kansas

    Kansas City, Kansas

  • Lexington, Kentucky

    Lexington, Kentucky

  • Scarborough, Maine

    Scarborough, Maine

  • Boston, Massachusettes

    Boston, Massachusetts

  • Boston Neuro Research Center

    North Dartmouth, Massachusetts

  • Farmington Hills, Michigan

    Farmington Hills, Michigan

  • West Bloomfield, Michigan

    West Bloomfield, Michigan

  • Saint Louis, Missouri

    St Louis, Missouri

  • Las Vegas, Nevada

    Las Vegas, Nevada

  • Las Vegas, Nevada

    Las Vegas, Nevada

  • Syracuse, New York

    Syracuse, New York

  • Asheville, North Carolina

    Asheville, North Carolina

  • Cincinnati, Ohio

    Cincinnati, Ohio

  • Cleveland, Ohio

    Cleveland, Ohio

  • Columbus, Ohio

    Columbus, Ohio

Showing 40 of 146 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.